TOMATO GETS INDUSTRY 'WAIT AND SEE'

SAN FRANCISCO -- In the hours after the Food and Drug Administration gave the go-ahead to Calgene to market its Flavr Savr tomato, the general feeling in the food industry about the future of the new bioengineered tomato seemed to be "wait and see."Industry leaders contacted by SN last Wednesday were reluctant to express even the ubiquitous "cautious optimism" for the future of the Flavr Savr.They

SAN FRANCISCO -- In the hours after the Food and Drug Administration gave the go-ahead to Calgene to market its Flavr Savr tomato, the general feeling in the food industry about the future of the new bioengineered tomato seemed to be "wait and see."

Register to view the full article